FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:553-556 February 6, 2003 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Weinshilboum, R. Related Article by Evans, W. E. PubMed Citation

One of the most striking features of modern medicines is how often they fail to work. Even when they do work, they are often associated with serious adverse reactions. Indeed, adverse reactions to drugs rank as one of the leading causes of death and illness in the developed world.¹ How can we improve the success rate?

The Human Genome Project and other advances have generated expectations that medicines can be customized to match the genetic makeup of patients, thereby dramatically improving efficacy and safety. These issues are examined in two review articles in this issue of the Journal.^2,3 Although . . . [Full Text of this Article]

Source Information

From the Department of Biology, University College London, London.

Related Letters:

Pharmacogenetics
Padrini R., Ferrari M., Carnes M., Noah L., Weinshilboum R., Evans W. E., McLeod H. L., Goldstein D. B., Vallance P.
Extract | Full Text | PDF  
N Engl J Med 2003; 348:2041-2043, May 15, 2003. Correspondence

This article has been cited by other articles:

• Casas, J. P., Cavalleri, G. L., Bautista, L. E., Smeeth, L., Humphries, S. E., Hingorani, A. D. (2006). Endothelial Nitric Oxide Synthase Gene Polymorphisms and Cardiovascular Disease: A HuGE Review. Am J Epidemiol 164: 921-935 [Abstract] [Full Text]  
• Ezzeldin, H. H., Diasio, R. B. (2006). Genetic testing in cancer therapeutics.. Clin. Cancer Res. 12: 4137-4141 [Full Text]  
• Evans, C. H., Rosier, R. N. (2005). Molecular Biology in Orthopaedics: The Advent of Molecular Orthopaedics. JBJS 87: 2550-2564 [Abstract] [Full Text]  
• Halliday, J. L, Collins, V. R, Aitken, M. A., Richards, M. P M, Olsson, C. A (2004). Genetics and public health--evolution, or revolution?. J. Epidemiol. Community Health 58: 894-899 [Abstract] [Full Text]  
• Brans, R., Laizane, D., Khan, A., Blomeke, B. (2004). N-Acetyltransferase 2 Genotyping: An Accurate and Feasible Approach for Simultaneous Detection of the Most Common NAT2 Alleles. Clin. Chem. 50: 1264-1266 [Full Text]  
• Soranzo, N., Cavalleri, G. L., Weale, M. E., Wood, N. W., Depondt, C., Marguerie, R., Sisodiya, S. M., Goldstein, D. B. (2004). Identifying Candidate Causal Variants Responsible for Altered Activity of the ABCB1 Multidrug Resistance Gene. Genome Res 14: 1333-1344 [Abstract] [Full Text]  
• Padrini, R., Ferrari, M., Carnes, M., Noah, L., Weinshilboum, R., Evans, W. E., McLeod, H. L., Goldstein, D. B., Vallance, P. (2003). Pharmacogenetics. NEJM 348: 2041-2043 [Full Text]